For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important ...

Lead program advancing to IND filing in H1 2025 for the treatment of X-linked chronic granulomatous disease (X-CGD) will be first in vivo HSC-directed therapy tested in humans Preclinical data to be ...

Funded by the UB Provost, the new Center for Cell, Gene and Tissue Engineering (CGTE) will be led by SUNY Distinguished Professor Stelios Andreadis. “I am very happy to announce the launch of the Cell ...

Regenerative medicine combines tissue engineering and cell therapies to repair or replace damaged human tissues and organs. Key applications include treating osteoarthritis with mesenchymal stem cells ...

Key market opportunities in the global competent cells market include rising demands in genetic engineering and synthetic ...

Luxury skincare is one of the largest markets for Asian consumers, particularly women, and recently Hong Kong has seen one of its own homegrown brands disrupting the industry. Founded by two young ...

Chimeric antigen receptor natural killer (CAR-NK) cell therapy is emerging as a promising next-generation immunotherapy with ...

New research may offer hope for endangered species Findings offer potential for regenerative medicine field Earlier study used different method for 'bipaternal' mice Jan 28 (Reuters) - Scientists in ...

Cardiovascular Reparative Medicine and Tissue Engineering (CRMTE) aims to develop future technologies and therapeutic strategies that will serve as treatment for cardiovascular disease. CRMTE includes ...

Acute myeloid leukemia (AML) isn’t the most commonly known cancer. It is, however, one of the deadliest—an awful rare malignancy of the blood and bone marrow whose victims are already older and frail, ...